Psychometric Evaluation of the Kansas City Cardiomyopathy Questionnaire in Men and Women With Heart Failure.
Psychometric Evaluation of the Kansas City Cardiomyopathy Questionnaire in Men and Women With Heart Failure.
复制标题
DOI:
10.1161/circheartfailure.120.008284
复制
发表时间:
2021-09
期刊:
影响因子:
--
通讯作者:
Spertus JA
中科院分区:
文献类型:
--
作者:
Hejjaji V;Tang Y;Coles T;Jones PG;Reeve BB;Mentz RJ;Spatz ES;Dunlay SM;Caldwell B;Saha A;Tarver ME;Tran A;Patel KK;Henke D;Piña IL;Spertus JA
The Kansas City Cardiomyopathy Questionnaire (KCCQ) has been psychometrically evaluated in multiple heart failure (HF) populations, but the comparability of its psychometric properties between men and women is unknown. Data from 3 clinical trials [1 in stable HF with preserved ejection fraction (HFpEF), 1 each in stable and acute HF with reduced ejection fraction (HFrEF)] and 1 prospective cohort study (stable HFrEF), incorporating 6773 men and 3612 women with HF, were used to compare the construct validity, internal and test-retest reliability, ability to detect change, predict mortality and hospitalizations and minimally important differences (MIDs) between the two genders. Interactions of the KCCQ overall summary (OS) and subdomain scores by gender were independently examined. The KCCQ-OS score correlated well with New York Heart Association functional class in both genders across patients with stable (correlation coefficient: −0.40 in men vs −0.49 in women) and acute (−0.37 in men vs −0.34 in women) HF. All KCCQ subdomains demonstrated concordant relationships with relevant comparison standards with no significant interactions by sex in 19 of 21 of these construct validity analyses. All KCCQ scores were equally predictive and other psychometric evaluations showed similar results by gender: test-retest reliability (Intra-class correlation coefficient 0.94 in men vs. 0.92 in women), responsive to change (Standardized response mean 1.01 in both genders), as were the MIDs and internal reliability. The psychometric properties of the KCCQ, in terms of validity, prognosis, reliability and sensitivity to change are comparable, in men and women with HFpEF and HFrEF.